FOCUS-3
"FOCUS-3" is a word and design mark owned by Axsome Therapeutics, Inc., filed at the USPTO on June 1, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).
- Status
- Awaiting publication
- Since October 14, 2026
- Filed
- June 1, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99858207
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 1 class
Who owns FOCUS-3
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Axsome Therapeutics, Inc.
AXSM · New York, United States
Representative
Brent A. Johnson
Procopio, Cory, Hargreaves & Savitch LLP
What the mark covers
The products and services FOCUS-3 is filed for, grouped by Nice class.
Medicated and pharmaceutical preparations for use in the treatment of ADHD; prescription medicines for the treatment of ADHD
What has happened so far
Steps recorded by the USPTO, newest first.
- Approved for pub - principal register
- Assigned to examiner
- Notice of design search code e-mailed
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About FOCUS-3
Who owns the trademark "FOCUS-3"?
The USPTO trademark "FOCUS-3" (application 99858207) is owned by Axsome Therapeutics, Inc.
What is the status of "FOCUS-3"?
Its status at the USPTO is: awaiting publication.
Get this data via the API
Everything on this page comes from the Signa API. Pull FOCUS-3 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019e8bed-b6fa-714c-80ff-bb2ddb0cd8a6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019e8bed-b6fa-714c-80ff-bb2ddb0cd8a6",
"object": "trademark",
"mark_text": "FOCUS-3",
"status": {
"primary": "pending",
"stage": "pending_publication"
},
"office_code": "US",
"application_number": "99858207",
"filing_date": "2026-06-01",
"nice_classes": [
5
],
"owners": [
{
"name": "Axsome Therapeutics, Inc.",
"entity_id": "ent_019ebba6-3220-71b6-8fee-f721d26ca090"
}
]
}